echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Clin Translational Gastroenterology: Circulating macrophage activation markers can predict the transplant-free survival rate of patients with primary sclerosing cholangitis

    Clin Translational Gastroenterology: Circulating macrophage activation markers can predict the transplant-free survival rate of patients with primary sclerosing cholangitis

    • Last Update: 2021-04-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Primary sclerosing cholangitis (PSC) is a progressive self- immune liver disease, and liver with chronic inflammation and symptoms of extrahepatic biliary stricture, and eventually leading to liver fibrosis and cirrhosis.


    Primary sclerosing cholangitis (PSC) is a progressive self- immune liver disease, and liver with chronic inflammation and symptoms of extrahepatic biliary stricture, and eventually leading to liver fibrosis and cirrhosis.


     

     

     

    This study included patients from two independent PSC cohorts at the Oslo Medical Center (n = 138) and Helsinki Medical Center (n = 159), and detected the levels of CD163 and sMR in the blood of the patients.


    This study included patients from two independent PSC cohorts at the Oslo Medical Center (n = 138) and Helsinki Medical Center (n = 159), and detected the levels of CD163 and sMR in the blood of the patients.


     

     

     

    The median (interquartile range) of sCD163 in the Oslo and Helsinki cohorts were 3.


    The median (interquartile range) of sCD163 in the Oslo and Helsinki cohorts were 3.


     

     

     

     

    This study confirmed that macrophage activation markers increase due to the severity of the disease, indicating that macrophages play an important role in PSC.


    This study confirmed that macrophage activation markers increase due to the severity of the disease, indicating that macrophages play an important role in PSC.


     

     

     

    Original source:

    Original source:

    Bossen, Lars .


    Bossen, Lars .
    E T Al.
    lww.
    com/ctg/Fulltext/2021/03000/Circulating_Macrophage_Activation_Markers_Predict.
    4.
    aspx" target="_blank" rel="noopener">Circulating Macrophage Activation-Markers Predict Transplant as Free Survival in Patients With Primary sclerosing cholangitis .
    Circulating Macrophage Activation-Markers Predict Transplant as Free Survival in Patients With Primary sclerosing cholangitis .
    Clinical Gastroenterology and the Translational .
    2021.
    In this message 
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.